Publications database

This document summarises the main issues concerning evaluation in the field of drug policy. Aimed at those managing rather than undertaking drug policy evaluations, the guide acts as an introduction, providing links...

This Manual is a revised edition of the Treatment demand indicator (TDI) protocol version 2.0 and presents updated guidelines for reporting data on people entering drug treatment in Europe. The TDI is...

The EMCDDA first published the Guidelines for the evaluation of drug prevention in 1998 to respond to a need expressed by professionals and policymakers to have a tool and stimulus to evaluate...

This Manual is a joint production by the EMCDDA and the Prevention Standards Partnership, and presents and describes basic and expert level quality standards for drug prevention. The standards cover all aspects...

Infectious diseases are among the most serious health consequences of injecting drug use and can lead to significant healthcare costs. Injecting drug users are vulnerable to a range of infectious and communicable...

Please note: a similar more recent and broader prevention resource is available here: European drug prevention quality standards This manual compiles basic but evidence-based prevention principles, planning rules and evaluation tips. Additionally...

Prices are an essential element of the illicit drug market, from both a supply and demand perspective. They are an indicator of drug availability and are an important tool for understanding the...

The main objective of the guidelines is to provide a European audience with basic information on the options, elements and procedures of drug-related treatment evaluation. The target readership includes professionals working in...

Policymakers and practitioners around the world acknowledge the importance of outreach work in the drug field, but the fact that it is a good idea does not mean that every project is...

Summary: These guidelines give detailed, step-by-step advice to programme-planners and evaluators on how to assess the different stages of drug-prevention interventions. Recently evaluated as one of the Centre's most utilised publications.